Pradaxa Lawsuit News and Information
The new blood thinner Pradaxa has been linked to an increased risk of serious and potentially life-threatening bleeding, leading many to question its safety. PRADAXA LAWSUIT STATUS: Users of Pradaxa who suffered severe internal bleeding, hemorrhages or other problems may be eligible to pursue a Pradaxa lawsuit. Lawyers are reviewing potential claims for individuals throughout […]
All Articles Tagged With: "Pradaxa"
A judge has asked parties involved in federal Pradaxa lawsuits to choose three cases each to be considered for early trials.
Boehringer Ingelheim attorneys are trying to block the deposition of the company’s two highest ranking executives over what they knew about Pradaxa bleeding problems.
Pradaxa again topped the list of drugs linked to the most number of adverse events that seriously harmed or killed patients, according to a new report.
In 2012, there was an increase in FDA adverse event reports involving patient deaths linked to drug side effects, and a number of drugs racked up large amounts of adverse event reports, according a new report by the Institute for Safe Medication Practices (ISMP)
Pradaxa bellwether trial discovery process is continuing, with first trials in MDL starting August 2014.
Despite the lack of an antidote, the makers of Pradaxa say their studies show bleeding events caused by the drug are no worse than those caused by warfarin.
An increasing number of adverse event warnings are being linked to the blood thinner Xarelto, according to a German newspaper.
Bleeding problems, strokes and heart attacks beset patients given Pradaxa during a clinical trial, leading scientists to abort the study due to Pradaxa health risks.
A federal judge cleared the way for a Pradaxa lawsuit to proceed on allegations that Boehringer Ingelheim failed to warn, but dismissed class action allegations.
A mediator has been appointed to meet monthly with parties in the Pradaxa MDL to discuss settling cases.
Contact a LawyerSubmit information about your potential case to be reviewed by an attorney.